Opinions
Fabrice Taylor
Eyecarrot Innovation
EYC-T
BUY
Jan 11, 2019
They have a vision correction technology that they have worked on fine tuning for some time. They have received amazing testimonials, including some from players in the NHL who had received concussions. They have received a large amount of money and feels they are ready to ready to commercialize the technology. He owns the product himself and owns the stock via a private placement.
N/A
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.